Search filters

List of works by John H Strickler

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.

scientific article published on 12 March 2018

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

scientific article published on 01 November 2019

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

scientific article published on 23 August 2019

A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

scientific article published on 26 July 2019

A within-trial cost-effectiveness analysis of panitumumab compared with bevacizumab in the first-line treatment of patients with wild-type RAS metastatic colorectal cancer in the US

scientific article published on 28 September 2018

Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response

scientific article published on 11 January 2019

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

scientific article published on 01 February 2019

Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer

scientific article published on April 3, 2012

Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer

scientific article published on 28 August 2018

Clinical applications of liquid biopsies in gastrointestinal oncology

scientific article

Development of a Novel c-MET-Based CTC Detection Platform.

scientific article published on 07 March 2016

EGFR Amplification as a Target in Gastroesophageal Adenocarcinoma: Do Anti-EGFR Therapies Deserve a Second Chance?

scientific article published on 01 June 2018

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.

scientific article published on 02 September 2017

First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors

article

Gastroesophageal heterotopia and HER2/neu overexpression in an adenocarcinoma arising from a small bowel duplication.

scientific article published in March 2014

Genomic landscape of cell-free DNA in patients with colorectal cancer.

scientific article

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

scientific article published on 31 May 2016

Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability

scientific article published on January 10, 2012

Palliative treatment of metastatic colorectal cancer: what is the optimal approach?

scientific article published on January 2014

Phase 1 Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients With Advanced Solid Tumors

scientific article published on 03 March 2020

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors

scientific article

Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors

scientific article

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

scientific article

Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study.

scientific article

TUMOR MUTATIONAL BURDEN AS A PREDICTOR OF IMMUNOTHERAPY RESPONSE: IS MORE ALWAYS BETTER?

scientific article published on 16 November 2020

Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches.

scientific article

The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer

scientific article published on 15 August 2019

Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice

scientific article published on 16 November 2018

Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.

scientific article

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper

scientific article published on 06 July 2020